MS/HP; ANRP ArrêtéArrêté N° 000377/MS/HP/ANRP/DG/DOL du 4 mars 2026
Currentness under review. Whether this instrument remains applicable is under review. Consult the later instruments and source context below before relying on it.
Arrêté N° 000377/MS/HP/ANRP/DG/DOL du 4 mars 2026 is the official MS/HP; ANRP identifier for “Arrêté déterminant les éléments constitutifs du dossier de demande de création, d’ouverture et d’exploitation, de renouvellement de l’autorisation d’ouverture et d’exploitation, de modifications et de transfert d’un établissement de fabrication et de préparation des produits de santé”. Arrêté N° 000377/MS/HP/ANRP/DG/DOL du 4 mars 2026 is the official identifier MS/HP; ANRP uses for this instrument.
- Instrument
- Arrêté
- Full name
- Arrêté N° 000377/MS/HP/ANRP/DG/DOL du 4 mars 2026
- Category
- Registration
- Source publication
- French
- Readable HTML
- 1 language version
- Published
- —
- Effective
- —
Open a language version
Each version has stable passage anchors for direct citations and highlighting. The readable text is generated from an authority source and does not replace the legally controlling publication.
Arrêté déterminant les éléments constitutifs du dossier de demande de création, d’ouverture et d’exploitation, de renouvellement de l’autorisation d’ouverture et d’exploitation, de modifications et de transfert d’un établissement de fabrication et de préparation des produits de santé
Signed ministerial order dated 4 March 2026 governing creation, operation, renewal, premises modifications and transfer of health-product manufacturing/preparation establishments; Article 2 includes medical devices. Article 14 specifies two months after the inspection request and a five-year operating permission. Article 18 requires permission for premises modifications; Article 19 treats transfer as a new opening. Article 22 gives existing establishments one year from Gazette publication to comply. All nine pages were fully read and visually checked. Duplicate Article 12, the Chapter V-to-VII jump, printed cross-references and the malformed si aucune effectuée sentence are preserved. Gazette publication and later amendments remain unverified. Article 7 expressly cites Decree 2025-149 Article 92; the parent original physical page 30 has been compared and confirms the responsible pharmacist authority, resources and quality-system duty. This resolved parent link does not establish product AMM approval or replace device importer licensing.
Arrêté N° 000377/MS/HP/ANRP/DG/DOL du 4 mars 2026 is the official identifier MS/HP; ANRP uses for this instrument. Always confirm the current consolidated text and transition provisions with the official source before filing.